PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Analyst Ratings

TSX-V:PHA • CA74052G1063

0.015 CAD
-0.01 (-25%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

40

ChartMill assigns a Buy % Consensus number of 40% to PHA.CA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 0.2. This target is 1260% above the current price.
  • PHA.CA was analyzed by 8 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about PHA.CA.
  • In the previous month the buy percentage consensus was at a similar level.
  • PHA.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
PHA.CA Historical Analyst RatingsPHA.CA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.020.200.200.200.21 - 1,246.67% 1,260.00% 1,260.00% 1,300.00%

Related screens

Find peers 30% below price target
PHA.CA Current Analyst RatingPHA.CA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2022-05-20 Acumen Capital Downgrade Buy
2021-08-30 Acumen Capital Downgrade Buy

PREMIER HEALTH OF AMERICA IN / PHA.CA FAQ

What is the price target for PHA stock?

8 analysts have analysed PHA.CA and the average price target is 0.2 CAD. This implies a price increase of 1260% is expected in the next year compared to the current price of 0.015.


What is the consensus rating for PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?

The consensus rating for PREMIER HEALTH OF AMERICA IN (PHA.CA) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.